Wed, Apr 23, 7:40 AM, Zacks
Amgen's Q1 Earnings Decline Y/Y - Analyst Blog
Amgen's first quarter results were disappointing with most of the products recording a sequential decline in sales.
Wed, Apr 23, 7:39 AM, Zacks
Revance Therapeutics (RVNC) Soars: Stock Up 25.8% - Tale of the Tape
Revance Therapeutics, Inc. was a big mover last session, as its shares rose nearly 26% on the day.